http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007133167-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-906 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 |
filingDate | 2006-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2007133167-A |
titleOfInvention | DRUG BASED ON A MIXTURE OF FLAVONOIDS WITH A FREE B-CYCLE AND FLAVANES, AS A THERAPEUTIC AGENT |
abstract | 1. A composition comprising a mixture of at least one flavonoid with a free B-cycle, at least one flavan, and at least one agent selected from the group consisting of an injectable anticoagulant agent, an oral anticoagulant agent, an antiplatelet agent, a non-steroidal anti-inflammatory drug (NSAID) or a selective cyclooxygenase-2 inhibitor (COX-2). ! 2. The composition according to claim 1, in which the ratio of the flavonoid with a free B-cycle to flavan in the specified composition is selected from the range from about 99: 1 flavonoid with a free B-cycle: flavan to about 1:99 flavonoid with a free B-cycle: flavana. ! 3. The composition according to claim 2, in which the ratio of the flavonoid with a free B-cycle: flavan in the present composition is approximately 85:15. ! 4. The composition according to claim 1, wherein said free B-cycle flavonoid is selected from the group of compounds having the following structure:! ! in which R1, R2, R3, R4 and R5 are independently selected from the group consisting of -H, -OH, -SH, OR, -SR, -NH2, -NHR, -NR2, -NR3 + X-, carbon, oxygen, nitrogen or sulfur, a glycoside from one or a combination of multiple sugars, including, but not limited to, aldopentoses, methylaldopentose, aldoghexoses, ketohexose and their chemical derivatives; ! in which R represents an alkyl group comprising 1-10 carbon atoms, and! X is selected from the group of pharmaceutically acceptable counterions, including hydroxyl, chloride, iodide, sulfate, phosphate, acetate, fluoride and carbonate. ! 5. The composition according to claim 1, wherein said flavan is selected from the group of compounds having the following structure:! ! in which R1, R2, R |
priorityDate | 2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468194443 |
Total number of triples: 32.